Sionna Therapeutics, Inc. Common Stock SION
i
Market datapartial · fetched 2026-11-13T00:47:42.382Z
Delta surfaceAlpaca · derived absolute-delta buckets · 2027-01-15
Calculation methodologyOptions historyIV: ThetaData historical Greeks, equal-weight mean of call/put 50-delta IV across the next four listed Friday-cycle expirations, including holiday shifts verified against ThetaData’s market calendar. Missing inputs leave gaps. Skew: equal-weight mean of put minus call IV across those four expirations. IV-implied move history: mean of each expiration’s average call/put IV multiplied by the square root of remaining calendar days divided by 365.25; percentage of spot, not a quoted straddle premium.
History dataPriceAlpaca · sip · 2026-11-12T21:26:17.702923016Z
FundamentalsAlpha Vantage · unavailable
Sionna Therapeutics, Inc. Common Stock options
Table
| Delta | Calls | Puts | ||||
|---|---|---|---|---|---|---|
| Pseudo strike | IV | B/E move | Pseudo strike | IV | B/E move | |
| 20Δ | 3.12 | 117.5% | 28.8% | |||
| 25Δ | 3.51 | 143.6% | 28.4% | |||
| 30Δ | 3.90 | 169.6% | 28.1% | |||
| 35Δ | 4.29 | 195.6% | 27.7% | |||
| 40Δ | 4.67 | 221.6% | 27.4% | |||
| 45Δ | 5.07 | 241.7% | 26.6% | |||
| 50Δ | 5.49 | 231.2% | 23.2% | |||
| 55Δ | 5.90 | 220.7% | 19.8% | |||
| 60Δ | 6.32 | 210.2% | 16.3% | |||
| 65Δ | 6.74 | 199.7% | 12.9% | |||
| 70Δ | 7.15 | 189.2% | 9.5% | |||
| 75Δ | ||||||
| 80Δ | 2.79 | 331.7% | 38.0% | |||
20Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- 3.12
- IV
- 117.5%
- B/E move
- 28.8%
25Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- 3.51
- IV
- 143.6%
- B/E move
- 28.4%
30Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- 3.90
- IV
- 169.6%
- B/E move
- 28.1%
35Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- 4.29
- IV
- 195.6%
- B/E move
- 27.7%
40Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- 4.67
- IV
- 221.6%
- B/E move
- 27.4%
45Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- 5.07
- IV
- 241.7%
- B/E move
- 26.6%
50Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- 5.49
- IV
- 231.2%
- B/E move
- 23.2%
55Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- 5.90
- IV
- 220.7%
- B/E move
- 19.8%
60Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- 6.32
- IV
- 210.2%
- B/E move
- 16.3%
65Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- 6.74
- IV
- 199.7%
- B/E move
- 12.9%
70Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- 7.15
- IV
- 189.2%
- B/E move
- 9.5%
75Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- IV
- B/E move
80Δ
- Pseudo strike
- 2.79
- IV
- 331.7%
- B/E move
- 38.0%
- Pseudo strike
- IV
- B/E move
Options history
Table
| Date | IV (%) |
|---|---|
| 270.03% |
Biotechnology
SLDB
Solid Biosciences Inc., a life sciences company, is dedicated to developing therapies for Duchenne muscular dystrophy (DMD) in the United States. The company is headquartered in…
More →SLN
Silence Therapeutics plc, a biotechnology company, is focused on the discovery and development of new ribonucleic acid (RNA) therapies in hematology, cardiovascular, and other…
More →SLS
SELLAS Life Sciences Group, Inc., an advanced-stage biopharmaceutical company, focuses on the development of new cancer immunotherapies for various indications of cancer in the…
More →SMMT
Description unavailable
More →SNDX
Description unavailable
More →SPRO
Description unavailable
More →